Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Bullboard Posts
Comment by vap1984on Jul 12, 2019 7:14pm
180 Views
Post# 29915830

RE:RE:Scotiabank

RE:RE:ScotiabankWe've all been through this a few times. But the following is true:

1). Bought Deal was poorly done and upset a lot of people off. That's probably behind us now but when the stock is $7.2 and you do a BD at $5.55 it is $&#@. However, long term they've got cash and solid foundation to build on.

2). Overall MJ market is going down again, summer is always slow but with edibles coming in the near future I suspect we see new highs for a lot of names. Canntrust didn't help but neither did Aphria, LHS or any others that caused the overall market to drop and everyone recovered nicely. 

3). Revenue to Market Cap LABs is the easiest to justify. Way under valued compared to many others out there today. 

The biggest 'x' factor for me on the downside is the concern that SPY, DOW, TSX are all on fire...what are the prices for MJ once they start to cool off...that part is scary. MJ has recovered 3 or 4 times but if the market shows any sign of recession the sell off will be much worse. Fingers crossed we make it to October without a global economic downfall.
Bullboard Posts